Nephrology and Advanced Kidney Disease
Clinical research activity is centered on chronic kidney disease at the most advanced stage, with a focus on patients requiring peritoneal dialysis. The sponsor’s trial landscape reflects interest in renal replacement care and treatment-related considerations in dialysis-dependent patients.
- CKD stage 5
- Peritoneal dialysis
- Automated peritoneal dialysis
Research activity is aligned with clinical questions relevant to dialysis management in patients without peritonitis.
Anti-infective Therapy
The sponsor’s research includes evaluation of cefepime, with interest in its use in the setting of intraperitoneal treatment. This places antibacterial therapy and infection-related care within its clinical focus.
- Cefepime
- Intraperitoneal administration
- Antibacterial treatment
The therapeutic emphasis is on infection management in patients receiving dialysis-based care.
Pharmacokinetics and Pharmacodynamics
Research interest extends to how cefepime behaves in blood plasma and dialysate, with attention to drug exposure and response in the dialysis environment. These areas support assessment of medication handling in patients undergoing cycler therapy.
- Blood plasma concentration
- Dialysate concentration
- Drug exposure
The sponsor’s trial activity is closely tied to therapeutic monitoring in peritoneal dialysis patients.
